Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit
NCT04645433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-11-27
Summary
Effect of Favipiravir and Lopinavir-Ritonavir on Mortality in a Tertiary Center Intensive Care Unit: Single Center Experience
Conditions
- Mortality
- Intensive Care Unit
Sponsors & Collaborators
-
Sisli Hamidiye Etfal Training and Research Hospital
lead OTHER
Principal Investigators
-
sultan acar sevinc · Sisli Hamidiye Etfal Education and Training Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-15
- Primary Completion
- 2020-05-15
- Completion
- 2020-05-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients
NCT04710329 ·Status: COMPLETED
-
Intensive Care Therapy of Covid-19 Disease in Germany
NCT04455451 ·Status: COMPLETED
-
Clinical Features of Severe Patients With COVID-19
NCT04450017 ·Status: COMPLETED
-
CoV-ICU Score, Intensive Care Unit, SARS-CoV-2
NCT04383483 ·Status: UNKNOWN
-
Outcomes of Patients With COVID-19 in the Intensive Care Unit
NCT04336345 ·Status: COMPLETED
-
COVID-19 Patients Admitted to the ICU
NCT04816786 ·Status: UNKNOWN
-
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180 ·Status: COMPLETED
-
Recovery of Patients From COVID-19 After Critical Illness
NCT04401254 ·Status: COMPLETED
-
Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın Turkey
NCT04789460 ·Status: COMPLETED
-
Clinical Characteristics, Outcomes and Risk Factors for Mortality in Pregnant/Puerperal Women With COVID-19 Admitted to ICU in Turkey: a Multicenter, Retrospective Study From a Middle-income Country.
NCT05930340 ·Status: COMPLETED
-
Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)
NCT04454372 ·Status: COMPLETED
-
EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTS
NCT05984407 ·Status: UNKNOWN
-
Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit
NCT04805645 ·Status: TERMINATED
-
The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU
NCT04800770 ·Status: UNKNOWN
-
Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia
NCT04423315 ·Status: COMPLETED
-
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
NCT04401111 ·Status: RECRUITING
-
Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit
NCT06037707 ·Status: COMPLETED
-
Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry
NCT04323787 ·Status: COMPLETED
-
Outcomes and Prognostic Factors in COVID-19
NCT04321265 ·Status: UNKNOWN
-
Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study
NCT04893031 ·Status: COMPLETED
-
Effectiveness of Convalescent Immune Plasma Therapy
NCT04442958 ·Status: COMPLETED ·Phase: NA
-
Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19
NCT04486521 ·Status: UNKNOWN
-
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey
NCT04304456 ·Status: UNKNOWN
-
Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit
NCT05058716 ·Status: UNKNOWN
-
ESICM UNITE COVID-19 Project (UNITE-COVID)
NCT04836065 ·Status: COMPLETED